TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.

Diabetes · 2010 · PMC2809956 · PMID 19934000

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

borderline significantP = 0.08so close (0.05 < p ≤ 0.1)

94.5 ± 15.4, P = 0.03), although they were borderline significant for difference in incretin effect (34.3 ± −4.3 vs. 45.5 ± 4.1%; P = 0.08).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.